- Home
- WYY vs XGN Comparison
WYY vs XGN Comparison
Compare WYY & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYY | XGN |
|---|---|---|
| Founded | 1991 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.3M | 110.7M |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WYY | XGN |
|---|---|---|
| Price | $6.77 | $7.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.29 |
| AVG Volume (30 Days) | ★ 406.3K | 349.0K |
| Earning Date | 08-13-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $150,545,364.00 | N/A |
| Revenue This Year | $12.26 | $11.02 |
| Revenue Next Year | $25.66 | $10.28 |
| P/E Ratio | $649.00 | ★ N/A |
| Revenue Growth | ★ 5.59 | N/A |
| 52 Week Low | $3.96 | $2.59 |
| 52 Week High | $24.30 | $12.23 |
Technical Indicators
Market Signals| Indicator | WYY | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 40.92 |
| Support Level | $4.34 | $6.83 |
| Resistance Level | $7.49 | $8.94 |
| Average True Range (ATR) | 0.41 | 0.56 |
| MACD | 0.09 | -0.15 |
| Stochastic Oscillator | 71.35 | 6.83 |
Price Performance
Historical ComparisonAbout WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.